Maitalon 30

Drospirenone, the active ingredient in Maitalon 30, is a combined oral contraceptive presented as an oral tablet for oral use. Together with ethinylestradiol, it works to prevent unintended pregnancy and to help regulate menstrual bleeding patterns in women of reproductive age.

GNH USA supplies Maitalon 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance for global distribution across Europe, Asia and the Americas, and supporting local healthcare partners with reliable logistics.

Maitalon 30, a combined oral contraceptive, is used to manage reproductive health by influencing hormonal regulation.

Contraception: prevents pregnancy by suppressing ovulation and altering cervical mucus. Menstrual cycle regulation: provides more predictable bleeding and reduces menstrual discomfort. Endometriosis‑associated pain: may lessen dysmenorrhea by stabilizing hormonal fluctuations.

Maitalon 30 may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in legs. - Pulmonary embolism: clot migration to lung vessels. - Severe hypertension: sudden increase in blood pressure. - Hepatic adenoma: rare benign liver tumor. - Allergic reactions: rash, swelling, or anaphylaxis.

Before prescribing Maitalon 30, clinicians should consider several safety factors.

Contraindicated in known thromboembolic disorders: avoid use due to clot risk. Avoid in smokers over 35 years: increased cardiovascular complications. Assess blood pressure before initiating: monitor regularly during therapy. Review liver function: hepatic impairment may require caution. Consider interactions with enzyme‑inducing drugs: may reduce contraceptive efficacy. Store at room temperature below 25°C: keep in original packaging, protect from moisture.

Maitalon 30 can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly lower hormone levels. - Antifungal azoles (e.g., ketoconazole): can increase circulating hormone concentrations. - Protease inhibitor antiretrovirals (e.g., ritonavir): may raise thrombosis risk.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (e.g., sertraline): may increase bleeding tendency. - Antihypertensives (e.g., ACE inhibitors): additive blood‑pressure effects possible. - Herbal supplements such as St. John’s wort: may diminish contraceptive effectiveness.